Latency-associated nuclear antigen of Kaposi sarcoma-associated herpesvirus promotes angiogenesis through targeting notch signaling effector Hey1
- PMID: 24523441
- DOI: 10.1158/0008-5472.CAN-13-1467
Latency-associated nuclear antigen of Kaposi sarcoma-associated herpesvirus promotes angiogenesis through targeting notch signaling effector Hey1
Abstract
Notch signaling has been implicated in the pathogenesis of Kaposi sarcoma. Kaposi sarcoma is an angioproliferative neoplasm that originates from Kaposi sarcoma-associated herpesvirus (KSHV) infection. Previously, we showed that the KSHV LANA protein can stabilize intracellular Notch in KSHV-infected tumor cells and promote cell proliferation. However, whether Notch signaling functions in pathologic angiogenesis of Kaposi sarcoma remains largely unknown. Hey1, an essential downstream effector of the Notch signaling pathway, has been demonstrated to play a fundamental role in vascular development. In the present study, we performed whole transcriptome, paired-end sequencing on three patient-matched clinical Kaposi sarcoma specimens and their corresponding adjacent stroma samples, with an average depth of 42 million reads per sample. Dll4, Hey1, and HeyL displayed significant upregulation in Kaposi sarcoma. Further verification based on immunohistochemistry analysis demonstrated that Hey1 was indeed highly expressed in Kaposi sarcoma lesions. Using the Matrigel plug assay, we showed that downregulation of Hey1 and γ-secretase inhibitor treatment caused dramatic reduction in the formation of new blood vessels in mice. Interestingly, LANA was responsible for the elevated level of Hey1 through inhibition of its degradation. Importantly, Hey1 stabilized by LANA promoted the neoplastic vasculature. Taken together, our data suggest that hijacking of the proangiogenic property of Hey1 by LANA is an important strategy utilized by KSHV to achieve pathologic angiogenesis and that Hey1 is a potential therapeutic target in Kaposi sarcoma.
©2014 AACR.
Similar articles
-
Cancer angiogenesis induced by Kaposi sarcoma-associated herpesvirus is mediated by EZH2.Cancer Res. 2012 Jul 15;72(14):3582-92. doi: 10.1158/0008-5472.CAN-11-2876. Epub 2012 May 16. Cancer Res. 2012. PMID: 22593192 Free PMC article.
-
Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count.J Med Virol. 2007 Oct;79(10):1562-8. doi: 10.1002/jmv.20949. J Med Virol. 2007. PMID: 17705173
-
Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling.Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8490-5. doi: 10.1073/pnas.1432843100. Epub 2003 Jun 27. Proc Natl Acad Sci U S A. 2003. PMID: 12832621 Free PMC article.
-
Kaposi sarcoma as a model of oncogenesis and cancer treatment.Expert Rev Anticancer Ther. 2007 Feb;7(2):211-20. doi: 10.1586/14737140.7.2.211. Expert Rev Anticancer Ther. 2007. PMID: 17288530 Review.
-
Deregulation of the Notch pathway as a common road in viral carcinogenesis.Rev Med Virol. 2018 Sep;28(5):e1988. doi: 10.1002/rmv.1988. Epub 2018 Jun 28. Rev Med Virol. 2018. PMID: 29956408 Review.
Cited by
-
The SH3BGR/STAT3 Pathway Regulates Cell Migration and Angiogenesis Induced by a Gammaherpesvirus MicroRNA.PLoS Pathog. 2016 Apr 29;12(4):e1005605. doi: 10.1371/journal.ppat.1005605. eCollection 2016 Apr. PLoS Pathog. 2016. PMID: 27128969 Free PMC article.
-
A KSHV microRNA enhances viral latency and induces angiogenesis by targeting GRK2 to activate the CXCR2/AKT pathway.Oncotarget. 2016 May 31;7(22):32286-305. doi: 10.18632/oncotarget.8591. Oncotarget. 2016. PMID: 27058419 Free PMC article.
-
Molecular Biology of KSHV in Relation to HIV/AIDS-Associated Oncogenesis.Cancer Treat Res. 2019;177:23-62. doi: 10.1007/978-3-030-03502-0_2. Cancer Treat Res. 2019. PMID: 30523620 Free PMC article.
-
An APE1 inhibitor reveals critical roles of the redox function of APE1 in KSHV replication and pathogenic phenotypes.PLoS Pathog. 2017 Apr 5;13(4):e1006289. doi: 10.1371/journal.ppat.1006289. eCollection 2017 Apr. PLoS Pathog. 2017. PMID: 28380040 Free PMC article.
-
Kaposi sarcoma herpesvirus pathogenesis.Philos Trans R Soc Lond B Biol Sci. 2017 Oct 19;372(1732):20160275. doi: 10.1098/rstb.2016.0275. Philos Trans R Soc Lond B Biol Sci. 2017. PMID: 28893942 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical